المؤلفون: Almaghlouth I; I. Almaghlouth, MBBS, MSc, Division of Rheumatology, Department of Medicine, University of Toronto, Ontario, Canada, and Rheumatology Unit, Department of Medicine, and College of Medicine Research Center, King Saud University, Saudi Arabia., Pullenayegum E; E. Pullenayegum, PhD, Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, and Program in Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada., Gladman DD; D.D. Gladman, MD, FRCPC, M.B. Urowitz, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto, and Centre for Prognosis in Rheumatic Diseases, University Health Network, and The Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Urowitz MB; D.D. Gladman, MD, FRCPC, M.B. Urowitz, MD, FRCPC, Division of Rheumatology, Department of Medicine, University of Toronto, and Centre for Prognosis in Rheumatic Diseases, University Health Network, and The Krembil Research Institute, University Health Network, Toronto, Ontario, Canada., Johnson SR; S.R. Johnson, MD, PhD, Division of Rheumatology, Department of Medicine, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. Sindhu.Johnson@uhn.ca.

المصدر: The Journal of rheumatology [J Rheumatol] 2021 Mar; Vol. 48 (3), pp. 321-325. Date of Electronic Publication: 2020 Jul 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Erythematosus, Systemic*/complications , Lupus Erythematosus, Systemic*/drug therapy , Rare Diseases*, Bias ; Humans ; Observational Studies as Topic ; Propensity Score ; Risk Factors